Pipeline

The potential of our medical devices and digital therapeutic platforms is being explored across a variety of neurodegenerative disorders.

Indication	Exploratory	Clinical Trials	Commercial
Alzheimer’s Disease	ExploratoryClinical TrialsCommercial
Mild Cognitive Impairment	ExploratoryClinical TrialsCommercial
Parkinson’s Disease	ExploratoryClinical TrialsCommercial
Aphasia	ExploratoryClinical TrialsCommercial
Dyslexia	ExploratoryClinical TrialsCommercial

News & Publications

Oscillo Biosciences2023-03-14T16:58:36-04:00October 10, 2022|News|

Oscillo Biosciences2023-03-14T16:58:36-04:00June 29, 2022|News|

Oscillo Biosciences2023-03-14T16:58:37-04:00June 24, 2022|Publications|